N/A
N=51
Smoking Cessation E-Visit
Smoking
Bottom Line
View on ClinicalTrials.gov: NCT04316260 ↗Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcome: Primary: Number of Participants Who Utilized Smoking Cessation Treatment — 15; 3 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Smoking cessation e-visit (Behavioral); Treatment As Usual (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Utilized Smoking Cessation Treatment |
14; 4 | — |
| PRIMARY Number of Participants Who Utilized Smoking Cessation Treatment |
14; 4 | — |
| PRIMARY Cigarettes Smoking |
15; 5 | — |
| PRIMARY Cigarettes Smoking |
15; 5 | — |
| PRIMARY Quit Attempts |
14; 12 | — |
| PRIMARY Quit Attempts |
14; 12 | — |
| PRIMARY 24-hour Quit Attempt |
11; 11 | — |
| PRIMARY 24-hour Quit Attempt |
11; 11 | — |
| PRIMARY Seven-day Point Prevalence Abstinence |
5; 1 | — |
| PRIMARY Seven-day Point Prevalence Abstinence |
5; 1 | — |
| PRIMARY Floating Abstinence |
7; 4 | — |
| PRIMARY Floating Abstinence |
7; 4 | — |
| SECONDARY E-visit Completion |
19 | — |
| SECONDARY Provider Fidelity |
27 | — |
| SECONDARY E-visit Ease of Use |
25 | — |
| SECONDARY Time to Complete the E-visit |
1.42 | — |
Summary
The goal of this study is to develop, refine, and complete preliminary feasibility testing of a smoking cessation electronic visit (e-visit) for implementation in primary care/family medicine. The investigators will conduct a feasibility RCT (N=51) of the smoking cessation e-visit as compared to treatment as usual (TAU), delivered via primary care, with primary objective to provide effect size estimates for a larger RCT. Primary outcomes cluster around: 1) treatment feasibility, 2) treatment acceptability, 3) treatment satisfaction, 4) evidence-based cessation treatment utilization, and 5) cessation-related outcomes (quit attempt incidence, abstinence). It is hypothesized that participants randomized to the e-visit condition as compared to those randomized to the TAU condition will have higher rates of cessation treatment utilization (medications, counseling) and superior cessation-related outcomes.
Eligibility Criteria
Inclusion Criteria
- current smoking, defined as smoking 5+ cigarettes/day, for 20+ days out of the last 30, for the last 6+ months
- age 18+
- enrolled in Epic's MyChart program or willing to sign up for MyChart
- possess a valid e-mail address that is checked daily to access follow-up assessments and MyChart messages
- English fluency
Exclusion Criteria
None
Data sourced from ClinicalTrials.gov (NCT04316260). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.